EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipids as Emerging Biomarkers in Neurodegenerative Diseases

Justin Wei, Li Chin Wong, Sebastian Boland

International Journal of Molecular Sciences · 21.12.2023 · 25 (1) · 131

DOI: 10.3390/ijms25010131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.12.2023. Verfasst von Justin Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Prevail Therapeutics, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomarkers are molecules that can be used to observe changes in an individual’s biochemical or medical status and provide information to aid diagnosis or treatment decisions. Dysregulation in lipid metabolism in the brain is a major risk factor for many neurodegenerative disorders, including frontotemporal dementia, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Thus, there is a growing interest in using lipids as biomarkers in neurodegenerative diseases, with the anionic phospholipid bis(monoacylglycerol)phosphate and (glyco-)sphingolipids being the most promising lipid classes thus far. In this review, we provide a general overview of lipid biology, provide examples of abnormal lysosomal lipid metabolism in neurodegenerative diseases, and discuss how these insights might offer novel and promising opportunities in biomarker development and therapeutic discovery. Finally, we discuss the challenges and opportunities of lipid biomarkers and biomarker panels in diagnosis, prognosis, and/or treatment response in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseParkinson DiseaseHumansBiomarkersMonoglycerides

Stichwörter der Autor:innen

Alzheimer’s diseaseGaucher diseaseNiemann–Pick diseaseParkinson’s diseaseTay–Sachs diseaseamyotrophic lateral sclerosisbiomarkersbis(monoacylglycero)phosphate (BMP)frontotemporal dementiagangliosidesglycosphingolipidslipidsmultiple sclerosisneurodegenerative diseasesprogranulin

Substanzen

BiomarkersMonoglycerides

Autor:innen und Institutionen

  • Prevail Therapeutics, a Wholly Owned Subsidiary of Eli Lilly and Company, New York, NY 10016, USA.

Zitieren

APA

Wei, J., Wong, L. C., & Boland, S. (2023). Lipids as Emerging Biomarkers in Neurodegenerative Diseases. International Journal of Molecular Sciences, 25(1), 131. https://doi.org/10.3390/ijms25010131

Vancouver

Wei J, Wong LC, Boland S. Lipids as Emerging Biomarkers in Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;25(1):131. doi:10.3390/ijms25010131

BibTeX
@article{Wei2023,
  author = {Wei, Justin and Wong, Li Chin and Boland, Sebastian},
  title = {Lipids as Emerging Biomarkers in Neurodegenerative Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {131},
  doi = {10.3390/ijms25010131}
}
Kostenlos starten →